David Hollinworth — World Congress on Rheumatic Heart Disease 2026 (WCRHD 2026)

Dr David HOLLINWORTH

Dr David Hollinworth is CEO of CamBris Cardiac, a UK company developing a polymer heart valve with outstanding durability, ease of manufacture and long term biostability, a unique combination to meet the needs of the RHD patients.

David’s career in the medical device industry includes leadership roles in both large and small companies including Medtronic and Artivion, as VP/GM for Europe, The Middle East and Africa. He holds a PhD in biochemistry and an MBA from London Business School.

11 - 14 November 2026
Pan Pacific Hotel, Perth, Australia

Have a question?
Contact the Congress Team

The World Congress on Rheumatic Heart Disease 2026 is being held on the lands of the Whadjuk Nyoongar people and we acknowledge them as Traditional Owners.
We acknowledge their continuing connection to land, waters and community, and acknowledge our responsibility to respect and to care for country.
We pay our respects to the Elders, past and present, and Aboriginal Elders of other communities who may attend the Congress.

Important Notice: Fraud Prevention and Official Communication
Please be vigilant regarding potentially fraudulent activity and suspicious email correspondence. All official communication from ASN Events will originate only from an @asnevents.net.au email address. We will never request payment via email containing bank transfer details without an official invoice.  All card payments must be made through our secure online payment gateway. If you receive any emails that appear suspicious or request payment, do not respond, click any links, or provide any information. Instead, contact us directly to verify the legitimacy of the communication.

Dr David HOLLINWORTH

11 - 14 November 2026Pan Pacific Hotel, Perth, Australia

Have a question?Contact the Congress Team

11 - 14 November 2026
Pan Pacific Hotel, Perth, Australia

Have a question?
Contact the Congress Team